The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin

Brain Research

Volumn 724, Issue 1, 1996, Pages 84-88

  Pasini, Augusto ^a,b   Tortorella, Alfonso ^a   Gale, Karen ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

bicuculline; deep piriform cortex; seizure; serotonin; substantia nigra; aminobutyric acid

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE 4 CHLOROPHENYLALANINE; 1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ANTICONVULSIVE AGENT; FLUOXETINE; GEPIRONE; METERGOLINE; RECEPTOR SUBTYPE; SEROTONIN AGONIST; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOLOGY; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PYRIFORM CORTEX; RAT; SEIZURE; SEROTONIN UPTAKE; SUBSTANTIA NIGRA;

EID: 0029941786     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00291-0     Document Type: Article

References (14)

1. Browning, R.A., Statnick, M.A., Dailey, J.W. and Jobe, P.C., Effect of intranigral fluoxetine on audiogenic seizures in genetically epilepsy prone rats (GEPRs), Soc. Neurosci., 19 (1993) 599.9.
2. Buterbaugh, G.G., Effect of drugs modifying central serotonergic function on the response of extensor and non extensor rats to maximal electroshock, Life Sci., 23 (1978) 2393-2904.
3. Buus Lassen, J., Potent and long-lasting potentiation of two 5-hydroxytropthophan-induced effects in mice by three selective 5-HT uptake inhibitors, Eur. J. Pharmacol., 47 (1978) 351-358.
4. Dailey, J.W., Van, Q.S., Mishra, P.K., Burger, R.L. and Jobe, P.C., Effects of fluoxetine on convulsions and brain serotonin as detected by microdialysis in genetically epilepsy-prone rats, J. Pharmacol. Exp. Ther., 260 (1992) 533-540.
5. Favale, E., Rubino, V., Mainardi, P., Lunardi, G. and Albano, C., Anticonvulsant effect of fluoxetine in humans, Neurology, 45 (1995) 1926-1927.
6. Leander, J.W., Fluoxetine, a selective serotonin-uptake inhibitor, enhances the anticonvulsant effect of phenytoin, carbamazepine, and ameltolide (LY2101116), Epilepsia, 33 (1992) 573-576.
7. Pasini, A., Tortorella, A. and Gale, K., Anticonvulsant effect of intranigral fluoxetine, Brain Res., 593 (1992) 287-290.
8. Pellegrino, L.J., Pellegrino, A.S. and Cushman, A.J., A Stereotaxic Atlas of the Rat Brain, Plenum, New York, 1979.
9. Piredda, S. and Gale K., Evidence that the deep prepiriform cortex contains a crucial epileptogenic site, Nature, 317 (1985) 623-625.
10. Prendiville, S. and Gale, K., Anticonvulsant effect of systemic fluoxetine on focally-evoked limbic motor seizure in rats, Epilepsia, 34 (1993) 381-384.
11. Sparks, D.L. and Bucktholtz, N.S., Combined inhibition of serotonin uptake and oxidative diamination attenuates audiogenic seizures in DBA/2J mice, Pharmacol. Biochem. Behav., 23 (1985) 753-757.
12. Trimble, M., Anlezark, G. and Meldrum, B., Seizure activity in photosensitive baboons following antidepressant drugs and the role of serotonergic mechanisms, Psychopharmacology, 51 (1977) 159-164.
13. Wernicke, J.F., The side effect profile and safety of fluoxetine, J. Clin. Psychiatry, 46 (1985) 59-67.
14. Yan, Q.S., Jobe, P.C., Cheong, J.H., Ko, K.H. and Dailey, J.W., Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy prone rats, Naunyn-Schmiedebergs Arch. Pharmacol., 350 (1994) 149-152.